The management of viral hepatitis in the setting of pregnancy requires special consideration.
There are five liver-specific viruses (hepatitis A, B, C, D, E), each with unique epidemiology …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and associated
morbidity and mortality worldwide. Short-course, oral, curative, direct-acting antiviral …

Hepatitis C virus (HCV) infection is a major source of morbidity and mortality in the United
States. HCV is transmitted primarily through parenteral exposures to infectious blood or …

Summary Background Hepatitis C virus (HCV) infection is increasing among pregnant
women because of the opioid epidemic, yet there are no interventions to reduce perinatal …

This first Practice Guidance on Reproductive Health from the American Association for the
Study of Liver Diseases (AASLD) is intended to be a comprehensive reference on …

The coronavirus disease 2019 (COVID-19) has dramatically challenged the healthcare
system of almost all countries. The authorities are struggling to minimize the mortality along …

The global prevalence of viral hepatitis is very high and seems to be rising over the years.
The infection can profoundly affect pregnant women causing significant maternal and …

Hepatitis C virus (HCV) infection is a silent killer that leads to rapid progression of liver
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …

In pregnancy, potential effects of infections on both mother and fetus must be considered.
Pregnant women are at increased risk of some infections due to physiologic changes of …

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections represent a major global
public health and economic burden, with an estimated 257 million and 71 million people …